- Review
Claudin 18.2 as a New Biomarker in Gastric Cancer—What Should We Know?
- Maria Cecília Mathias-Machado,
- Victor Hugo Fonseca de Jesus,
- Alexandre Jácome,
- Mauro Daniel Donadio,
- Marcelo Porfirio Sunagua Aruquipa,
- João Fogacci,
- Renato Guerino Cunha,
- Leonard Medeiros da Silva and
- Renata D’Alpino Peixoto
Gastric cancer (GC) remains a formidable global health challenge, ranking among the top-five causes of cancer-related deaths worldwide. The majority of patients face advanced stages at diagnosis, with a mere 6% five-year survival rate. First-line tre...

